Gilead Sciences
GILD
#102
Rank
C$261.78 B
Marketcap
C$211.12
Share price
2.17%
Change (1 day)
36.36%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): C$10.24

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$10.38. In 2025 the company made an earnings per share (EPS) of C$9.58 an increase over its 2024 EPS that were of C$0.53.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$10.246.82%
2025C$9.581702.63%
2024C$0.53-91.65%
2023C$6.3723.98%
2022C$5.14-25.86%
2021C$6.934850%
2020C$0.14-97.64%
2019C$5.930.9%
2018C$5.8818.71%
2017C$4.95-64.88%
2016C$14.10-18.45%
2015C$17.2955.28%
2014C$11.14296.02%
2013C$2.8117.89%
2012C$2.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.22 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.83-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.88-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.49 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.26 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$13.08 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.74-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$23.80 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$5.00-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA